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Abstract
Objectives: If patients change their perspective due to treatment, this may alter the
way they conceptualize, prioritize, or calibrate questionnaire items. These psycholog-
ical changes, also called “response shifts,” may pose a threat to the measurement of
therapeutic change in patients. Therefore, it is important to test the occurrence of
response shift in patients across their treatment.
Methods: This study focused on self‐reported psychological distress/
psychopathology in a naturalistic sample of 206 psychiatric outpatients. Longitudinal
measurement invariance tests were computed across treatment in order to detect
response shifts.
Results: Compared with before treatment, post‐treatment psychopathology scores
showed an increase in model fit and factor loading, suggesting that symptoms became
more coherently interrelated within their psychopathology domains. Reconceptualiza-
tion (depression/mood) and reprioritization (somatic and cognitive problems) response
shift types were found in several items. We found no recalibration response shift.
Conclusion: This study provides further evidence that response shift can occur in
adult psychiatric patients across their mental health treatment. Future research is
needed to determine whether response shift implies an unwanted potential bias in
treatment evaluation or a desired cognitive change intended by treatment.
KEYWORDS
longitudinal measurement invariance, mental health treatment, psychopathology, response shift,
Symptom Questionnaire‐48 (SQ‐48)
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1 | INTRODUCTION
It is generally assumed that the subjective standard of measurement
used in self‐report instruments is the same between time points and
that comparisons made between them are valid measures of true
change. However, there are indications that subjective standards of
patients and their interpretations of, and response to, itemsmay change
across treatment. For instance, how patients view their symptoms may
change due to recovery from the underlying mental disorder, improved
cognitive abilities, and psychoeducation, which can affect how patients
respond to self‐report items (e.g., Fokkema, Smits, Kelderman, &
Cuijpers, 2013). This phenomenon is called a “response shift”
(Golembiewski, Billingsley, & Yeager, 1976; Howard et al., 1979; Nolte,
Mierke, Fischer, & Rose, 2016; Sprangers & Schwartz, 1999;Wu, 2016).
If persons change their perspective, this may alter the way they
conceptualize, prioritize, and calibrate items. Consequently, three main
types of response shifts have been identified: reconceptualization,
reprioritization, recalibration (Nolte et al., 2016; Schwartz & Sprangers,
1999; Sprangers & Schwartz, 1999). Reconceptualization means that
patients redefine the meaning of a concept such as “depression.” For
instance, before treatment, patients had never considered somatic
symptoms (e.g., sleep problems) as a component of their depression.
However, after successful treatment, patients may consider somatic
symptoms as part of their depression (Oort, 2005). Reprioritization
means that the importance of specific symptoms changes in the over-
all measurement (Oort, 2005). For example, before treatment, when
patients do not work due to sick leave, they may score items
concerning concentration as not so important. However, after treat-
ment, when patients resume their work, they may score these items
as more important because they realize that concentration is crucial
to their job performance. Finally, recalibration means a change in the
patient's interpretation of response scale values. For example, after
treatment, the Likert‐score of 1 (rarely) on the suicidal ideation item
may represent another level of depression and rumination about sui-
cide than before treatment. Uniform recalibration means a recalibration
of the item scale, which influences all response options within an item
and all subjects to the same extent and in the same direction. Non‐uni-
form recalibration means that the recalibration of the item scale differs
in extent or direction across subjects and/or response options
(Fokkema et al., 2013; Oort, 2005).
Although response shifts are not necessarily negative (as they
represent adaptation), they may pose a threat to the measurement
of change (Czobor & Volavka, 1996; Kaushal, 2016; Millsap, 2012;
Nolte et al., 2016; Oort, 2005). For this reason, some authors prefer
the term “response shift bias” instead of “response shift” (e.g., Fried
et al., 2016; Kaushal, 2016; Shaw, Cross, & Zubrick, 2015; Tugwell
& Knottnerus, 2014). Failing to account for response shift may result
in overreporting or underreporting of true change. Response shift
has been raised as a possible explanation for null or negative effects
of some intervention programmes (e.g., Nixon & Werner, 2010;
Smith, Schneider, Smith, & Ananiadou, 2004). Therefore, it is advised
to consider testing for this potential source of bias (Barclay & Tate,
2014; Fokkema et al., 2013; Howard, Mattacola, Howell, &
Lattermann, 2011; Ring, Höfer, Heuston, Harris, & O'Boyle, 2005;
Shaw et al., 2015).
Several methods for testing/dealing with response shift have been
proposed (e.g., Barclay‐Goddard, Epstein, & Mayo, 2009; Schwartz
et al., 2013; Shaw et al., 2015). Two principally used methods are ret-
rospective pretest (Hill & Betz, 2005; Howard, 1980; Howard &
Dailey, 1979; Meyer, Richter, & Raspe, 2013; Nieuwkerk, Tollenaar,
Oort, & Sprangers, 2007; Schwartz & Sprangers, 2010) and testing
measurement invariance in confirmatory factor analyses (CFAs) or
structural equation models (e.g., Millsap & Yun‐Tein, 2004; Oort,
2005; Vandenberg & Lance, 2000). The former would be appropriate
in evaluation studies using a single‐item measure, and the latter, when
a multi‐item measure is used (Shaw et al., 2015; e.g., present study).
Studies have already convincingly shown that response shift can
occur across treatment of a chronic somatic disease (for an overview:
e.g., Schwartz et al., 2006; Vanier, Leplège, Hardouin, Sébille, &
Falissard, 2015). To date, only three studies specifically aimed at
response shift testing regarding pretreatment versus post‐treatment
self‐report scores amongst adult psychiatric patients (Fokkema et al.,
2013; Nolte et al., 2016; Smith, Woodman, Harvey, & Battersby,
2016). All three studies revealed response shift, especially concerning
depression items.
The purpose of this study is to contribute to research on response
shift testing across mental health treatment in adult psychiatric
patients. So far, no response shift studies were focused on a broad
spectrum of psychopathological symptoms. Therefore, this study
focused on psychopathology measured with the self‐report Symptom
Questionnaire‐48 (SQ‐48) which was designed as public domain ques-
tionnaire in the context of Routine Outcome Monitoring (ROM;
Carlier, Schulte‐Van Maaren, et al., 2012; Carlier et al., 2017). We
tested the occurrence of all response shift types across treatment in
a naturalistic sample of secondary psychiatric care outpatients. We
expect above all response shift in the domain depression/mood,
because it was suggested that depression in particular is sensitive to
response shift (e.g., Nolte et al., 2016).
2 | METHODS
2.1 | Design and procedure
This study was conducted by the Department of Psychiatry of Leiden
University Medical Centre (LUMC), using already available ROM data
of a previous Dutch multicenter pre‐post treatment study (Carlier
et al., 2017). Time between pre‐post assessments varied
(Table 1), depending on how ROM was implemented (e.g., monthly,
every 3–4 months, later). Consequently, the second assessment was
not necessarily the end assessment (possibly interim assessment),
nor was it due to meeting treatment goals or patient disengagement.
For the purpose of this study, we selected ROM data of outpatients
with common mental disorders who had both pre‐post treatment data
of SQ‐48 (Carlier et al., 2017). General criteria to be eligible for ROM
are: all psychiatric inpatients and outpatients, who are literate and
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have sufficient command of the Dutch language, and who are willing
and able to complete self‐report instruments. Most common reason
that patients are not eligible for ROM is insufficient command of the
Dutch language, in which case they get treatment without ROM (de
Beurs et al., 2011; instruments for non‐Dutch‐speaking patients in
preparation). Within ROM, patients are enrolled in treatment (instead
of research). Dropout or missing data in ROM generally have to do
with patients who stop their treatment or no‐shows at their ROM
measurement appointment, respectively. In the present study, we
had no information regarding such data.
Patients are administered a battery of measures which continues for
as long as the patient is being treated. ROM measures generally
may include: psychiatric interview (optional, Mini‐International
Neuropsychiatric interview; Sheehan et al., 1998; Van Vliet & De Beurs,
2006), observer‐rated instruments (optional), and self‐report question-
naires (generic and disorder‐specific). Measures are administered
by independent assessors (trained research nurses/psychologists)
through computerized self‐report, which prevents missing data as
item‐completion is necessary for progression to the next item. For a
detailed description of Dutch ROM, see de Beurs et al. (2011). Dutch
ROM is fairly comparable with ROM abroad (e.g., USA, UK) in terms of
objectives; ROM data are collected systematically to assess treatment
effectiveness in everyday clinical practice, to inform clinicians and
patients about treatment progress (Carlier, Meuldijk, et al., 2012; Lam-
bert, 2017; Lambert,Whipple, & Kleinstäuber, 2018). Also, implementa-
tion of ROM in clinical practice forms a common challenge in most
countries (e.g., Boswell, Kraus, Miller, & Lambert, 2015; Essock, Olfson,
& Hogan, 2015; Roe, Drake, & Slade, 2015). A possible difference with
ROM abroad may be that Dutch ROM uses a less frequent but more
comprehensive assessment battery (de Beurs et al., 2011).
Patients were treated in six comparable Dutch treatment centres
(see Acknowledgements) of similar size and patient care organization.
All patients were treated by psychiatrists or clinical psychologists/
psychotherapists according to the principle of stepped‐care and
(inter)national evidence‐based treatment guidelines (e.g., Cuijpers
et al., 2013; Van Fenema, Van Der Wee, Bauer, Witte, & Zitman,
2012) concerning pharmacotherapy or psychotherapy (mainly cogni-
tive behavioral therapy, CBT) or a combination of both (Van Fenema
et al., 2012; Van Noorden, Van Fenema, van der Wee, Zitman, &
Giltay, 2012). Treatment was not assigned, controlled, or influenced
by the research team (Carlier et al., 2017).
The Medical Ethical Committee of the LUMC approved the general
study protocol in which ROM is considered as an integral part of treat-
ment process (no written informed consent is required). Patients may
refuse ROMmeasurement and/or the anonymous use of their ROMdata
for scientific research without consequences (i.e., they receive necessary
treatment). If patients refuse to take part in scientific research, their ROM
data are removed from the ROM database (Carlier et al., 2017).
2.2 | Participants
The study sample consisted of 206 outpatients (see Table 1).
Table 1 shows that there were 135 (65.5%) females and 71 (34.5%)
males. Their age ranged from 19 to 71 years, with a mean of 38.4 years
(SD = 12.1). Patients were mainly diagnosed with depressive and/or
anxiety disorders (together 76.2%, Table 1). Other disorders mostly
included somatoform disorders (about 14.3%, not in table). The mean
interval between pretreatment and post‐treatment assessments was
18.9 weeks (SD = 7.6) (Table 1; Carlier et al., 2017).
2.3 | Measure
2.3.1 | Symptom Questionnaire‐48 (SQ‐48)
The SQ‐48 is a generic self‐report questionnaire that assesses
common psychopathological symptoms within seven subscales (seven
factors with a total of 37 items): Aggression (four items),
Mood/depression (six items), Somatic complaints (seven items), Anxi-
ety (six items), Social phobia (five items), Agoraphobia (four items),
Cognitive complaints (five items). Two additional subscales do not
measure psychopathology and were therefore excluded for this study
(Carlier et al., 2017): Vitality/optimism (six items), Work/study func-
tioning (six items). All SQ‐48 items are for frequency on a 5‐point
Likert scale (0: Never, 1: Rarely, 2: Sometimes, 3: Often, and 4: Very
often). Mean administration time is 5.4 min (SD = 1.4; Carlier,
Schulte‐Van Maaren, et al., 2012). The total score of the SQ‐48 in this
study is based on the sum score of the seven psychopathology sub-
scales (range from 0 to 148). A high total score indicates high levels
of psychopathology/psychological distress.
CFA has been computed and demonstrated that the hypothesized
factor structure of the SQ‐48 fitted well with the data in both a
reference‐group of non‐patients (n = 516; comparative fit index
[CFI] = 0.96; root mean square error of approximation (RMSEA) = 0.05)
TABLE 1 Baseline characteristics of study sample (N = 206)
Female gender (%) 65.5
Age (years) 38.4 ± 12.1 (19–71)
Interval between pre/post (weeks) 18.9 ± 7.6 (4–42)
Ethnicity (%)
• Dutch 76.6
• Other 5.8
• Unknown 17.5
Psychopathology (%):
• Anxiety Disorders 36.4
• Unipolar depressive disorders 39.8
• Other 21.4
• No diagnosis 2.4
Note. Data are expressed as percentages or means ± standard deviation,
with range. Sample was used to test the factor invariance of the SQ‐48.
Other psychopathology: somatoform disorders (most); personality disor-
ders; bipolar disorders; disorders usually first diagnosed in infancy, child-
hood or adolescence; adjustment disorders; impulse‐control disorders not
elsewhere classified; dissociative disorders; eating disorders; mental disor-
ders due to a general medical condition not elsewhere classified. On the
basis of Table S1 of Carlier et al. (2017) and adapted for this study.
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and a patient‐group with mainly depression and anxiety disorder
(n = 242; CFI = 0.97; RMSEA = 0.06; Carlier, Schulte‐Van Maaren,
et al., 2012). The SQ‐48 showed good internal consistency as well as
good convergent and divergent validity in psychiatric outpatients
and healthy reference‐group (Carlier, Schulte‐Van Maaren, et al.,
2012). It also showed excellent test–retest reliability and good respon-
siveness to therapeutic change in psychiatric outpatients (Carlier et al.,
2017). Detailed information about the development of the SQ‐48 is
described elsewhere (see Carlier, Schulte‐Van Maaren, et al., 2012).
The Dutch SQ‐48 was translated into English according to
evidence‐based guidelines for translation and cultural adaptations of
questionnaires (Carlier, Schulte‐Van Maaren, et al., 2012; Wild et al.,
2005; see Supporting information). Given that this study was Dutch,
we have used the Dutch SQ‐48 version.
2.4 | Statistical analyses
First, changes in total and sub‐scores of SQ‐48 were analysed using a
doubly multivariate design with repeated measures in order to under-
stand the impact of treatment and in preparation for response shift
testing (Lix & Hinds, 2004). Cohen's d effect size was calculated.
Because post‐treatment SD could be affected by treatment, we used
baseline SD when computing Cohen's d (Cohen, 1992). Bear in mind
that these effect sizes can only be interpreted when we find at least
partial measurement invariance in most of the items (Byrne,
Shavelson, & Muthén, 1989; Reise, Widaman, & Pugh, 1993;
Steenkamp & Baumgartner, 1998; Vandenberg & Lance, 2000; see
Appendix). Moreover, it may be affected by population heterogeneity
(Greenland, Schlesaelman, & Criqui, 1986).
Second, we tested for response shift (longitudinal measurement
invariance tests). Current statistical guidelines for response shift test-
ing recommend using CFA (e.g., Elhai et al., 2013; Fokkema et al.,
2013; Millsap & Hartog, 1988; Wu, 2016). We used weighted least
squares means and variance (WLSMV) adjusted estimator (Beauducel
& Herzberg, 2006; Hirschfeld & von Brachel, 2014), which takes the
ordinal nature and non‐normal distribution of the data into account
and resulted in the best model fit (e.g., Muthén & Asparouhov,
2002). Valid results were found in studies that also used WLSMV with
similar sample sizes (e.g., Hukkelberg & Ogden, 2016; Nussbeck, Eid, &
Lischetzke, 2006). In the original study of the SQ‐48 (Carlier, Schulte‐
Van Maaren, et al., 2012), the factor structure was based on seven
correlated psychopathology subscales with one layer, which is also
used in this study (see Figure S1). Before computing longitudinal mea-
surement invariance tests, we tested the model fit with the following
fit indices (Hawes, Mulvey, Schubert, & Pardini, 2014): CFI (acceptable
when CFI > 0.95; Hu & Bentler, 1999), Tucker‐Lewis Index (acceptable
when TLI > 0.95; Hu & Bentler, 1999), and RMSEA (acceptable when
RMSEA < 0.06; Hu & Bentler, 1999). Standardized mean difference
(d) with 95% confidence interval (CI), adjusted for response shift, is
reported (Oort, 2005; Del Re, 2013). CFAs were conducted using R‐
package Lavaan (version 0.5.17 and 0.5.18; Rosseel et al., 2016).
More detailed information about CFA (including Models A, B, C,
and D) and its interpretation in terms of response shift types can be
found in the Appendix and Figure S1.
3 | RESULTS
3.1 | Change in severity of psychopathology
Table 2 summarizes tests of pretreatment and post‐treatment mean
total scores (sum of subscale scores) and subscales.
The total and subscores decreased at post‐treatment. The total
score of the SQ‐48 at pretreatment ranged from seven to 121 with
a mean of 66.66 (SD = 21.54), and at post‐treatment it ranged from
four to 124 with a mean of 57.25 (SD = 25.84), which was a statisti-
cally significant decrease (psychological distress*treatment: p < .001;
η2 = .193; F = 6.78; df = 7).
TABLE 2 Comparison of SQ‐48 total and sub scores of pretreatment and post‐treatment data (N = 206)
Pre‐treatment Post‐treatment
SQ‐48 sub scale Items Mean (SD) Mean (SD) Mean difference (SE) t p d*
Aggression 4 5.1 (3.5) 4.6 (3.6) 0.5 (0.25) 1.86 .065 0.14
Agoraphobia 4 6.7 (4.2) 5.7 (4.4) 1.0 (0.23) 4.38 <.001 0.24
Anxiety 6 13.6 (5.5) 11.6 (6.3) 2.1 (0.35) 5.91 <.001 0.36
Cognitive complaints 5 9.8 (4.1) 8.4 (4.6) 1.4 (0.25) 5.71 <.001 0.34
Mood 6 12.2 (3.9) 10.8 (4.1) 1.4 (0.27) 5.14 <.001 0.36
Somatic complaints 7 10.2 (5.6) 8.5 (5.9) 1.7 (0.33) 5.28 <.001 0.30
Social phobia 5 9.0 (4.3) 7.6 (4.5) 1.4 (0.28) 4.85 <.001 0.33
SQ‐48 total scorea 37 66.7 (21.5) 57.3 (25.8) 9.4 (1.46) 6.46 <.001 0.45
Note. Changes in total and sub scores are analysed using a doubly multivariate design with repeated measures. p values are two‐tailed. SD = standard devi-
ation. SE = standard error. t = paired t‐test. d* = Cohen's d calculated with pretreatment SD. SQ‐48 = Symptom Questionnaire‐48.
aSQ‐48 total score composed of the following seven psychopathology sub scales: Mood, Anxiety, Somatic complaints, Social phobia, Agoraphobia, Aggres-
sion, and Cognitive complaints.
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All subscale scores at pre‐ and post‐treatment showed significant
decreases (all p‐values <0.001; Table 2), except for subscale Aggres-
sion. The Cohen's d effect size ranged from 0.14 to 0.45, which is con-
sidered small (Cohen, 1992).
3.2 | Change in overall factor structure;
reconceptualization
The 7‐factor psychopathology structure of the SQ‐48 (Figure S1) was
analysed at both pretreatment and post‐treatment. The factor struc-
ture had a poor fit at pretreatment (not in table): CFI of 0.87, TLI of
0.86, RMSEA with a value of 0.143 (90% CI [0.139, 0.148]). The
post‐treatment CFI of 0.92 and TLI of 0.91 indicate a better factor
fit (not in table). The RMSEA of 0.183 (90% CI [0.179, 0.188]) indicate
a worsening in factor fit. We computed a bootstrap analysis with
9,999 replicates and found that the difference in fit (ΔCFI) was signif-
icantly different from zero with the following 90% CI [−0.056, −0.007].
The configural model (Model A), an unconstrained model with pre-
treatment and post‐treatment combined resulted in a CFI of 0.90,
TLI of 0.89, and RMSEA of 0.165 (90% CI [0.161, 0.168]). When
looking at subscale‐specific fit indices, we see that the Mood subscale
has a substantial lower CFI value (CFI = 0.78) compared with the other
subscales (see Table 4). When looking at RMSEA, we found that four
subscales had a poor fit: Mood, Anxiety, Somatic complaints, and Cog-
nitive problems. Compared with the other fit indices, RMSEA is gener-
ally considered less reliable with relative modest sample sizes and
large amount of parameters (Jackson, 2003).
All item‐specific pretreatment and post‐treatment factor loadings,
threshold estimates for the four item categories, and residuals (residuals
of pretreatment fixed to 1 with theta parametrization, see Appendix) of
the configural model are demonstrated in Table 3. At pretreatment, all
factor loadings were significant with p values of <.001 with the excep-
tion of Item 13 (“I considered my death or suicide,” p = .46), Item 19 (“I
did not want to live anymore,” p = .05), Item 38 (“I felt hopeless,”
p = .48), and Item 43 (“I wanted to hit people if I was provoked,”
p = .22; see Table 3). These items, all within the Mood and Aggression
subscale, loaded in the opposite direction (negative). At post‐treatment,
we again saw that these items loaded negatively, but only Item 43
(Aggression) was not statistically significant (p = .16). We found that
the factor loading of all items increased with the exceptions of Item
10 (“I argued with others”), Item 1 (“I was short of breath with minimal
effort”), Item 25 (“I did not dare to go alone to a crowded shop”), and
Item 36 (“I felt uncomfortable when other people looked at me”).
The factor correlations of the factor model are presented in Table
S1. All correlations were generally strong with a significance of
p < .001, except for the correlations between Aggression and Agora-
phobia (p = .189 at pretreatment and p = .008 at post‐treatment).
Coefficients ranged from 0.099 (Aggression and Agoraphobia at pre-
treatment) till 0.902 (Cognitive problems and Anxiety at post‐
treatment). Correlations increased at post‐treatment compared with
pretreatment; exceptions were correlations between Mood and Cog-
nitive problems, Mood and Anxiety, and Anxiety and Aggression.
The overall factor fit increased significantly over treatment and
criteria for configural invariance could not be met. We found four
items that loaded negatively on their common factor. Item 13 (“I con-
sidered my death or suicide”), Item 19 (“I did not want to live any-
more”), and Item 38 (“I felt hopeless”) seemed to form a separate
latent factor consisting of suicidal ideation and hopelessness. Subse-
quently, the model did not fit well within the Mood subscale which
had consequences for the overall model fit. These negative factor
loadings increased and were considered insignificant at pretreatment
and significant at post‐treatment. Consequently, although items 13,
19, and 38 were already distinct from the rest of the mood items, an
increase in factor loadings after treatment indicated a change in item
scale meaning or reconceptualization response shift.
3.3 | Factor metrics over time; reprioritization
In order to examine factor loading change in the factor model, the load-
ings were constrained between time points within themetric invariance
model (Model B; Table 2). The change in factor fit was analysed
(Table 4). The fit of the model remained similar with a CFI of 0.90 after
constraining the factor loadings (Model B), with a significant decrease in
chi‐square (Model A versus Model B; p = .002) but an insignificant
decrease in CFI (ΔCFI 0.005). When looking at subscale specific ΔCFI,
we found partial metric variance in factors Mood, Somatic complaints,
and Cognitive problems (ΔCFI < 0.01; Model A versus B). When looking
at item level, we found that item 26 within the Somatic subscale and
item 47 within the Cognitive subscale caused these significant results.
Themetric variance detected in items 3, 7, and 40was due to reconcep-
tualization in the otherMood items, rather than reprioritization (see par-
agraph 3.2). Lifting constraints on these items resulted in invariant
outcomes (Table 4, Table S2). Within these items, the factor loadings
increased, suggesting reprioritization response shift.
3.4 | Thresholds over time; uniform recalibration
Thresholds are constrained between pretreatment and post‐treatment
within the partial Strong invariance model (Model C; Table S3).
Because Items 3, 7, 26, 40, and 47 were not invariant in the metric
model, they were kept from further constraints in the strong model.
Differences in thresholds between pretreatment and post‐treatment
were analysed by testing the change in factor fit between Model B
and Model C. The overall model fit remained the same (CFI = 0.90).
The chi‐square difference tests per factor and for all factors combined
were insignificant and ΔCFI did not exceed 0.01 (Model B versus C).
No uniform change in measurement or uniform recalibration response
shift could be detected.
3.5 | Residual variances over time; non‐uniform
recalibration
In order to test for change in residual variance between pretreatment and
post‐treatment, residual variance was constrained between time points
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TABLE 3 Standardized parameter estimates for the configural invariance model of the longitudinal analysis
Loadings T1 T2 Residuals
Factor Item T1 T2
Threshold
1
Threshold
2
Threshold
3
Threshold
4
Threshold
1
Threshold
2
Threshold
3
Threshold
4 T1 T2
Agression 10 0.76 (0.07) 0.71 (0.06) −0.47 (0.09) −0.01 (0.09) 0.67 (0.10) 1.19 (0.11) −0.33 (0.09) 0.21 (0.09) 0.77 (0.10) 1.33 (0.12) ‐ 0.47 (0.06)
16 0.89 (0.06) >0.99 (0.07) −0.28 (0.09) 0.26 (0.09) 0.73 (0.10) 1.42 (0.13) −0.04 (0.09) 0.45 (0.09) 1.03 (0.11) 1.71 (0.15) ‐ 0.08 (0.09)
21 0.58 (0.07) 0.59 (0.07) −0.12 (0.09) 0.37 (0.09) 1.06 (0.11) 1.66 (0.15) 0.04 (0.09) 0.51 (0.09) 1.20 (0.11) 1.66 (0.15) ‐ 0.65 (0.06)
43 −0.13 (0.10) −0.16 (0.11) −0.41 (0.09) 0.37 (0.09) 1.24 (0.12) 2.34 (0.26) −0.45 (0.09) 0.26 (0.09) 1.03 (0.11) 1.61 (0.14) ‐ 0.98 (0.02)
Agoraphobia 4 0.83 (0.04) 0.90 (0.03) −1.19 (0.11) −0.76 (0.10) 0.05 (0.09) 1.24 (0.12) −0.94 (0.10) −0.43 (0.09) 0.39 (0.09) 1.22 (0.12) ‐ 0.24 (0.04)
8 0.73 (0.04) 0.83 (0.03) −0.49 (0.09) −0.13 (0.09) 0.34 (0.09) 1.22 (0.12) −0.30 (0.09) 0.15 (0.09) 0.68 (0.10) 1.36 (0.12) ‐ 0.36 (0.04)
14 0.67 (0.06) 0.79 (0.05) 0.04 (0.09) 0.45 (0.09) 1.08 (0.11) 1.61 (0.14) 0.20 (0.09) 0.68 (0.10) 1.08 (0.11) 1.46 (0.13) ‐ 0.45 (0.05)
25 0.86 (0.04) 0.84 (0.03) −0.48 (0.09) −0.17 (0.09) 0.39 (0.09) 1.10 (0.11) −0.39 (0.09) 0.06 (0.09) 0.70 (0.10) 1.19 (0.11) ‐ 0.30 (0.04)
Anxiety 24 0.69 (0.04) 0.74 (0.04) −0.94 (0.10) −0.49 (0.09) 0.35 (0.09) 1.17 (0.11) −0.86 (0.10) −0.17 (0.09) 0.65 (0.10) 1.24 (0.12) ‐ 0.48 (0.04)
28 0.81 (0.03) 0.84 (0.02) −0.55 (0.09) −0.18 (0.09) 0.51 (0.09) 1.39 (0.13) −0.43 (0.09) 0.06 (0.09) 0.59 (0.09) 1.36 (0.12) ‐ 0.32 (0.03)
33 0.75 (0.03) 0.83 (0.02) −1.14 (0.11) −0.65 (0.10) 0.07 (0.09) 1.14 (0.11) −0.75 (0.10) −0.35 (0.09) 0.41 (0.09) 1.22 (0.12) ‐ 0.35 (0.03)
41 0.83 (0.03) 0.89 (0.02) −1.61 (0.14) −1.06 (0.11) −0.30 (0.09) 0.73 (0.10) −1.19 (0.11) −0.51 (0.09) 0.25 (0.09) 1.06 (0.11) ‐ 0.25 (0.03)
46 0.82 (0.03) 0.89 (0.02) −1.10 (0.11) −0.75 (0.10) 0.04 (0.09) 0.96 (0.10) −0.86 (0.10) −0.31 (0.09) 0.30 (0.09) 1.12 (0.11) ‐ 0.25 (0.03)
48 0.76 (0.03) 0.83 (0.03) −1.89 (0.18) −1.24 (0.12) −0.48 (0.09) 0.56 (0.09) −1.33 (0.12) −0.85 (0.10) −0.05 (0.09) 0.85 (0.10) ‐ 0.36 (0.04)
Cognitive 2 0.53 (0.05) 0.65 (0.05) −0.52 (0.09) −0.15 (0.09) 0.59 (0.09) 1.83 (0.17) −0.45 (0.09) 0.07 (0.09) 0.94 (0.10) 1.97 (0.19) ‐ 0.64 (0.04)
problems 6 0.56 (0.05) 0.71 (0.04) −0.75 (0.10) −0.37 (0.09) 0.61 (0.09) 1.39 (0.13) −0.62 (0.09) −0.07 (0.09) 0.71 (0.10) 1.53 (0.14) ‐ 0.57 (0.04)
39 0.76 (0.04) 0.85 (0.03) −1.19 (0.11) −0.64 (0.09) 0.13 (0.09) 0.99 (0.11) −0.86 (0.10) −0.39 (0.09) 0.45 (0.09) 1.22 (0.12) ‐ 0.34 (0.03)
44 0.41 (0.07) 0.55 (0.05) −0.32 (0.09) 0.02 (0.09) 0.47 (0.09) 1.39 (0.13) −0.21 (0.09) 0.18 (0.09) 0.76 (0.10) 1.36 (0.12) ‐ 0.75 (0.04)
47 0.69 (0.04) 0.84 (0.03) −1.83 (0.17) −1.14 (0.11) −0.30 (0.09) 0.68 (0.10) −1.25 (0.12) −0.73 (0.10) 0.16 (0.09) 1.06 (0.11) ‐ 0.39 (0.04)
Mood 3 0.76 (0.04) 0.85 (0.04) −1.17 (0.11) −0.71 (0.10) 0.17 (0.09) 1.22 (0.12) −0.96 (0.10) −0.44 (0.09) 0.54 (0.09) 1.57 (0.14) ‐ 0.38 (0.04)
7 0.72 (0.04) 0.85 (0.04) −0.49 (0.13) −0.86 (0.10) −0.04 (0.09) 0.94 (0.10) −1.03 (0.11) −0.47 (0.09) 0.39 (0.09) 1.33 (0.12) ‐ 0.39 (0.04)
13 −0.06 (0.07) −0.46 (0.06) −0.78 (0.10) 0.00 (0.09) 0.83 (0.10) 1.76 (0.16) −0.58 (0.09) −0.06 (0.09) 0.86 (0.10) 1.83 (0.17) ‐ 0.93 (0.03)
19 −0.14 (0.07) −0.50 (0.06) −0.94 (0.10) −0.09 (0.09) 0.76 (0.10) 1.76 (0.16) −0.73 (0.10) −0.17 (0.09) 0.83 (0.10) 1.66 (0.15) ‐ 0.91 (0.03)
38 −0.06 (0.08) −0.35 (0.06) −1.39 (0.13) −0.51 (0.09) 0.43 (0.09) 1.53 (0.14) −1.17 (0.11) −0.31 (0.09) 0.56 (0.09) 1.49 (0.13) ‐ 0.96 (0.02)
40 0.71 (0.04) 0.89 (0.04) −1.39 (0.13) −0.92 (0.10) −0.05 (0.09) 0.96 (0.10) −1.10 (0.10) −0.59 (0.09) 0.32 (0.09) 1.19 (0.11) ‐ 0.36 (0.04)
Somatic 1 0.72 (0.04) 0.69 (0.04) −0.83 (0.10) −0.22 (0.09) 0.58 (0.09) 1.24 (0.12) −0.67 (0.10) 0.04 (0.09) 0.64 (0.09) 1.39 (0.13) ‐ 0.53 (0.04)
complaints 5 0.77 (0.04) 0.89 (0.03) −0.55 (0.09) −0.13 (0.09) 0.65 (0.10) 1.14 (0.11) −0.34 (0.09) 0.15 (0.09) 0.83 (0.10) 1.33 (0.12) ‐ 0.30 (0.04)
11 0.52 (0.06) 0.61 (0.05) −0.55 (0.09) 0.01 (0.09) 0.96 (0.10) 1.89 (0.18) −0.25 (0.09) 0.37 (0.09) 1.12 (0.11) 1.83 (0.17) ‐ 0.67 (0.04)
17 0.63 (0.05) 0.72 (0.04) −0.52 (0.09) −0.09 (0.09) 0.68 (0.10) 1.46 (0.13) −0.32 (0.09) 0.12 (0.09) 0.92 (0.10) 1.27 (0.12) ‐ 0.54 (0.04)
22 0.55 (0.06) 0.68 (0.04) −0.44 (0.09) 0.10 (0.09) 0.88 (0.10) 1.61 (0.14) −0.30 (0.09) 0.28 (0.09) 0.97 (0.10) 1.66 (0.15) ‐ 0.60 (0.04)
(Continues)
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within the strict invariance model. Strict invariance assumes that the
residual variance does not change during treatment. In order to assess
partial strict invariance, residual variance is constrained between pre-
treatment andpost‐treatment for all factors combined aswell as each fac-
tor separately. Because strict measurement invariance was estimated
with theta parameterization, which fixes residual variances to 1, item spe-
cific residuals could not be interpreted (Table S4). Because variance was
found in the metric model, no constraints were conducted for Item 3, 7,
26, 40, and 47. The overall model fit remained similar (CFI = 0.90).
Although the chi‐square difference test was significant for most factors,
the ΔCFI did not exceeded the cutoff of <0.01 (Model C versus D;
p > .05; ΔCFI < .01; Table 4), suggesting partial strict variance. This indi-
cates that no shift in subjective standards of measurement or response
scale values (non‐uniform recalibration) could be detected.
Finally, we analysed the standardized mean differences (d) between
pretreatment and post‐treatment, adjusted for response shift. No sig-
nificant decreases or increases in Cohen's dwere found. Response shift
effect sizes (95%CI) were: Aggression 0.25 (95%CI [0.05, 0.44]), Agora-
phobia 0.25 (95% CI [0.05, 0.44]), Anxiety 0.36 (95% CI [0.16, 0.56]),
Cognitive problems 0.32 (95% CI [0.13, 0.51]), Mood 0.37 (95% CI
[0.07, 0.45]), Somatic complaints 0.29 (95% CI [0.10, 0.48]), and Social
phobia 0.32 (95% CI [0.13, 0.52]). The final model parameters of the
fully constrained model are presented inTable S4.
4 | DISCUSSION
We tested the occurrence of response shift concerning self‐reported
psychopathology in adult psychiatric outpatients across their mental
health treatment. We found pretreatment and post‐treatment differ-
ences in factor structure and item factor loadings. In terms of response
shift can be concluded that we found reconceptualization within the
Mood subscale: items consisting of suicidal ideation and hopelessness
became more distinct, and patients seemed to approach suicidal idea-
tion after treatment as a separate concept from depression. So, it is
possible that a considerable proportion of our sample may have less
mood‐related symptoms after treatment without experiencing a
decrease in suicidal ideations (see also Bringmann, Lemmens, Huibers,
Borsboom, & Tuerlinckx, 2015; Nock, Hwang, Sampson, & Kessler,
2010). Second, we found reprioritization within at least two items of
the subscales Somatic complaints and Cognitive problems. After treat-
ment, patients seemed to place more value on these problems. Per-
haps cognitive and somatic problems became more important when
patients returned to work after sick leave. In conclusion, our hypothe-
sis about response shift in especially the subscale depression/mood
was only partly confirmed, as we also found response shift in other
subscales. This may imply that not only depression is sensitive to
response shift but also other psychopathology.
Our results are largely in line with current literature which indicates
that response shift seems to be the rule rather than the exception. Only
three studies were focused specifically on response shift in psychiatric
patients (Fokkema et al., 2013; Nolte et al., 2016; Smith et al., 2016)
and all found some level of response shift. Other relevant mental healthTA
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studies without specific focus on response shift showed mixed results
regarding its occurrence. Five studies in different psychiatric popula-
tions, using self‐report and/or clinician‐report instruments, found
response shift indications: Barbosa‐Leiker, McPherson, Mamey, Burns,
and Roll (2014); Czobor and Volavka (1996); Elhai et al. (2013); Fried
et al. (2016); Boucekine et al. (2015). However, no response shift was
found in the mental health studies by Quilty et al. (2013) with
clinician‐rated scale and by de Beurs, Fokkema, de Groot, de Keijser,
and Kerkhof (2015) with self‐report scale.
There is discussion on how strict the requirements should be
concerning testing response shift by longitudinal measurement invari-
ance (e.g., Fokkema et al., 2013). A first view states that full measurement
invariance is an assumption that is too strict and, therefore, that compar-
isons of means across treatment are still meaningful when partial
TABLE 4 Comparison of pretreatment and post‐treatment partial equality constraints concerning SQ‐48 sub scales using partial measurement
invariance procedures (N = 206).
Models
Fit
indices Mood Anxiety
Somatic
complaints Socialphobia Agoraphobia Agression
Cognitive
problems All factors
Configural (Model A) χ2 842.05 63.47 196.23 12.29 4.33 4.18 36.98 7969.70
df 18 18 28 10 4 4 10 1216
CFI 0.783 0.995 0.941 0.999 >0.999 >0.999 0.984 0.901
RMSEA 0.473 0.111 0.171 0.033 0.020 0.015 0.115 0.165
Metric (Model B) χ2 911.99 109.57 243.77 21.94 27.03 8.66 85.72 8372.70
df 24 24 35 15 8 8 15 1253
CFI 0.766 0.990 0.926 0.996 0.994 0.999 0.958 0.896
RMSEA 0.425 0.132 0.171 0.048 0.108 0.020 0.152 0.166
Partial Metric (Model B)a χ2 863.06 109.57 213.83 21.94 27.03 8.66 58.45 8331.85
df 21 24 34 15 8 8 28 1248
CFI 0.778 0.990 0.937 0.996 0.994 0.999 0.981 0.897
RMSEA 0.442 0.132 0.161 0.048 0.108 0.020 0.080 0.166
Partial Strong (Model C)a χ2 860.64 111.03 217.18 35.69 28.12 15.13 55.10 8259.03
df 26 41 50 29 19 19 24 1332
CFI 0.780 0.992 0.941 0.996 0.997 >0.999 0.981 0.899
RMSEA 0.396 0.091 0.128 0.034 0.048 <0.001 0.080 0.159
Partial Strict (Model D)a χ2 870.91 141.18 234.66 42.90 39.05 23.05 65.43 8424.66
df 29 47 56 34 23 23 28 1364
CFI 0.778 0.989 0.937 0.995 0.995 >0.999 0.978 0.897
RMSEA 0.376 0.099 0.125 0.036 0.058 0.003 0.081 0.159
χ2Diff 26.39 11.29 15.88 4.52 11.33 2.81 23.51 37.55
A vs. B Δdf 6 6 7 5 4 4 5 37
p <.001 .008 .003 .255 .005 .431 <.001 .002
ΔCFI 0.017 −0.005 0.014 0.003 0.006 0.001 0.026 0.005
χ2Diff 14.29 11.29 7.12 4.52 11.33 2.81 12.82 35.24
A vs. Ba Δdf 3 6 6 5 4 4 3 32
p 0.001 0.008 0.124 0.255 0.005 0.431 0.006 0.002
ΔCFI 0.005 0.005 0.004 0.003 0.006 0.001 0.010 0.005
χ2Diff 1.04 0.39 1.30 5.49 0.34 2.85 1.56 11.99
Ba vs. Ca Δdf 5 17 16 14 11 11 10 84
p >.999 .999 .999 .691 .996 .865 >.999 >.999
ΔCFI −0.002 −0.002 0.004 <0.001 −0.003 −0.001 0.002 0.002
χ2Diff 13.21 12.40 11.89 6.66 8.60 8.02 10.87 31.70
Ca vs. Da Δdf 3 6 6 5 4 4 4 32
p .002 .006 .024 .170 .025 .066 .019 .027
ΔCFI 0.002 0.003 0.004 0.001 0.002 <0.001 0.004 0.002
Note. Analyses are conducted for all factors (sub scales) combined and separately for the sub scales. A = Configural model, no parameters constrained;
B = Partial Metric model, factor loadings are constrained to be equal; Bᵃ = Partial Metric model, invariant factor loadings are constrained to be equal;
Cᵇ = Partial Strong model, invariant variable thresholds and factor invariant loadings constrained to be equal; Dᶜ = Partial Strict model, invariant residual
variances, invariant variable thresholds, and invariant factor loadings constrained to be equal. All constraints are computed with WLSMV estimation and
theta parameterization. SQ‐48 = Symptom Questionnaire‐48. χ2 = Chi‐square test df = degrees of freedom for Ch‐square test. CFI = comparative fit index.
χ2Diff = Chi‐square difference test. Δdf = degrees of freedom of Chi‐square difference test. p = p value. ΔCFI = delta comparative fit index.
aLifting the equality constraints on loadings of items 3, 7, 26, 40, and 47
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invariance is obtained and at least one itemwithin each factor is invariant
(Byrne et al., 1989; Steenkamp & Baumgartner, 1998). A second view is
more strict and states that most (subscale) items should be invariant in
order to make meaningful comparisons of the mean (Reise et al., 1993;
Vandenberg & Lance, 2000; Wu, 2016). A third view assumes that true
change in scores may be directly linked to respondents' changing per-
spective as a result of adaption, coping, or treatment (Boucekine et al.,
2015;Oort, Visser, & Sprangers, 2009). In this view, response shift should
not be considered as a measurement bias but as a true change.
Our study can be approached with all three views. Although we
found response shift, this was present within a limited amount of
items. This had no significant effect on the standardized mean differ-
ence between pretreatment and post‐treatment. Additionally, our
patients were mainly treated with CBT, which can cause a shift in cog-
nition and therefore may result in response shift. This is in line with
response shift theory, which assumes that changes in a person's health
status (e.g., diagnosis and treatment) are the requisite catalyst for
response shift (Rapkin & Schwartz, 2004; Sprangers & Schwartz,
1999). This was confirmed by Wu who found response shift across
treatment in depressed adolescents (Wu, 2015) but not in nonclinical
adolescents (Wu, 2016). Accordingly, Ahmed, Sawatzky, Levesque,
Ehrmann‐Feldman, and Schwartz (2014) found no response shift in
chronic physically ill individuals with stable physical health, which sup-
ports the assumption that response shift is not expected in patients
with relatively stable health conditions (Ahmed et al., 2014). Finally,
there may also be other potential explanations for our results then
response shift. One of these alternative explanations is a decrease of
variability of items after treatment (Fried et al., 2016). Due to a
decrease of severity, items may approach a mean of zero, resulting
in small SDs that cannot exhibit substantial correlations anymore. This
would explain variance of certain symptoms that may have low sever-
ity amongst a treated sample (e.g., acute suicidal ideation). However, in
our study the SDs slightly increased and factor fit increased, suggest-
ing that it is unlikely that this explains our findings.
A strength of this study is that ROMdatawere collected in a natural-
istic sample of real‐life patients. We measured a wide range of psycho-
logical symptoms in a broad sample of adult psychiatric outpatients.
Also, we have examined all response shift types, which has been done
so far in only two adult mental health care studies (Fokkema et al.,
2013; Nolte et al., 2016). This study also has limitations. We had no
detailed individual information on therapists or types of treatments.
So, for instance, it is not clear whether response shift varied by treat-
ment type (psychotherapy and pharmacotherapy). Also, treatment
length for participants varied, depending on the specific treatment
required and its progress. It may be noted, however, that response shift
already can occur after only 1 month of mental health treatment (e.g.,
Elhai et al., 2013; Latini et al., 2009). Moreover, after dividing our data
in treatment longer—and shorter than 16 weeks (median), we found
response shifts in the same items for both strata, with exception of Item
38 and 39 (Tables S5 and S6). Note that these sensitivity analyses
should be interpret with caution because of limited sample sizes. Our
sample size was also not large enough to examine potential subgroup
differences regarding response shift between mental disorders. Finally,
generalization of our results is at least limited to Dutch‐speaking
patients. Generalization may also be limited by our study population
(outpatients), our design (observational pre‐post‐treatment), and our
instrument (generic self‐report questionnaire). However, this is unlikely
because response shift has also been found concerning inpatients (e.g.,
Elhai et al., 2013; Nolte et al., 2016), randomized controlled trials (e.g.,
Fokkema et al., 2013), disease‐specific self‐report questionnaires (e.g.
Elhai et al., 2013; Fokkema et al., 2013; Fried et al., 2016), and
clinician‐rated instruments (e.g., Fried et al., 2016).
Future research with multiple follow‐ups could specify more
exactly what type of response shift occurs at what moment across
treatment (soon after the beginning of treatment or after a certain
duration of it). Second, further research may evaluate the relative
importance of the response shift types (Jakola, Solheim, Gulati, &
Sagberg, 2016). For example, it was suggested that recalibration is
the only true response shift, because reprioritization and reconceptu-
alization can be seen as coping strategies instead of response shifts
(Blome & Augustin, 2015; Gerlich et al., 2016). Third, more research
is needed on predictors of which psychiatric patients may experience
response shift (Daltroy, Larson, Eaton, Phillips, & Liang, 1999;
Sprangers & Schwartz, 1999; Wu, 2016; Rapkin, Garcia, Michael,
Zhang, & Schwartz, 2017). For instance, response shift seemed more
likely to occur in psychotherapy patients than in those treated with
medication (Fokkema et al., 2013; Fried et al., 2016; Uher et al.,
2008). Additionally, further response shift research is needed to exam-
ine possible differences in mental disorders.
On the whole, this study provides additional evidence that
response shift may occur in adult psychiatric patients across treat-
ment. The exact meaning of this response shift is not clear: is it an
unwanted potential bias in treatment evaluation or mainly a coping
strategy and desired cognitive change intended by mental health
treatment (e.g., CBT)? Future research in this area would be able to
give more clarity on this question.
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APPENDIX
THE USE OF CONFIRMATORY FACTOR
ANALYSIS (CFA) IN THE CONTEXT OF
RESPONSE SHIFT TESTING
A CFA framework allows for testing the structure of item sets and
how they measure hypothesized latent variables. Pretreatment CFA
can be compared with post‐treatment CFA frameworks in order to
detect if response shifts occurred during treatment. In a series of
nested CFA models (Models A, B, C, and D in the present study), hier-
archal equality constraints on items' factor loadings, thresholds, and
residual variances were applied. Model A contains a CFA model with-
out any constraints between timepoints; Model B has loadings
constrained to be equal between timepoints; Model C contains
constrained loadings and thresholds; Model D contains constrained
loadings, thresholds and residuals. A drop in model fit after constraint
indicates inequality across time points (longitudinal measurement
invariance tests; Fokkema et al., 2013; Millsap, 2012; Vandenberg &
Lance, 2000; Widaman, Ferrer, & Conger, 2010). For example, when
Model B has a substantial lower model fit compared with Model A,
this suggests that loadings were substantially different between
time‐points.
Equality was tested with chi‐square difference tests. However, as
these tests are highly dependent on sample size, the more robust ΔCFI
was calculated to see whether the CFI value was substantially differ-
ent between CFA models (ΔCFI > 0.01;Gregorich, 2006; Kim, 2005 ;
Rutkowski, 2013). A decrease in model fit is considered significant
with a chi‐square difference test (χ) above p = .05, in conjunction with
a ΔCFI above 0.01 (Chen, Curran, Bollen, Kirby, & Paxton, 2008;
Cheung & Rensvold, 2002; Hu & Bentler, 1998). When full measure-
ment invariance could not be obtained, the equality constraints of
the non‐invariant parameters were lifted in order to assess partial
measurement invariance (Oort, 2005; Wu, 2016).
These longitudinal measurement invariance tests were used as a
framework to test the occurrence of four types of response shifts:
reconceptualization, reprioritization, uniform recalibration, and non‐
uniform recalibration.
Reconceptualization
A factor model is assumed to be configural invariant, meaning that the
same factor loading pattern is present at both time points (pre/post).
Each item should load on the same common factor, both at pretreat-
ment and post‐treatment. When items load on different latent factors
after treatment, this is indicative for a shift in concept. Violation of
configural invariance is indicative for the occurrence of reconceptual-
ization (Oort, 2005).
To test for configural invariance, the 7‐factor structure was fitted
for both pretreatment and post‐treatment (Gregorich, 2006). The fac-
tor model is assumed to be configural invariant, when the difference
of fit indices between pretreatment and post‐models is insignificant.
We used bootstrapping (9,999 replicates) to test whether this differ-
ence is statistically significant (Canty, 2002; Oort, 2005). Furthermore,
we compared the item‐specific factor loadings in order to check for
salient changes of factor loading directions.
Reprioritization
The metric invariance model requires corresponding factor loadings to
be equal across time points. An increase or decrease in factor loadings
after treatment suggests that there is response shift in the form of
reprioritization (Oort, 2005); for example, items seem to be more or
less indicative for a certain latent factor. We computed a configural
model with both time points (pretreatment and post‐treatment) com-
bined, without equality constraints (Model A, see Table 4). We then
computed a metric model with the factor loadings constrained equally
between time points (Model B, seeTable 4); if factor loadings between
pretreatment and post‐treatment are similar, this should result in a
similar model fit. A chi‐square difference test was conducted and a
ΔCFI was calculated to measure whether the chi‐square and CFI signif-
icantly decreased after constraint (χ = p < .05; ΔCFI > 0.01). When the
factor fit of Model B and Model A are similar, the result of the chi‐
square difference test should be insignificant and the ΔCFI should be
smaller than 0.01 (Gregorich, 2006; Kim, 2005; Rutkowski, 2013).
Analyses were computed for the whole 7‐factor psychopathology
model at once as well as per subscale separately. If invariance on sub-
scale level was not met, we further examined partial item‐level mea-
surement invariance (Wu, 2016).
Uniform recalibration
To test for uniform recalibration response shift, we must assess
whether the regressions of items onto their associated common fac-
tors yield similar threshold values across time‐points. When equality
is established, the model shows strong invariance, meaning that there
is no indication for uniform recalibration (Oort, 2005). In other words,
patients appraise the SQ‐48 item response options after treatment the
same as before treatment. However, when there is variance, treat-
ment may have changed a patient's idea of the amount of the hope-
lessness indicated by the answer option “often” (item 38; Oort,
2005). We computed a third model with both factor loadings (when
invariant in the metric model) and thresholds constraint to be equal
between time points (strong invariance model; Model C, see Table 4)
and compared the factor fit with that of Model B. If threshold values
are equal between pre‐ and post‐treatment, model fit should be similar
after thresholds are constrained to be equal between time points. A
chi‐square difference test in conjunction with ΔCFI was calculated in
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order to quantify the differentiations (χ = p > .05; ΔCFI <0.01;
Gregorich, 2006; Rutkowski, 2013). Strong invariance tests were com-
puted for the whole 7‐factor model at once, per subscale separately.
When reprioritization or recalibration was found, the variant items
were excluded from further constraints (partial measurement invari-
ance; Wu, 2016).
Non‐uniform recalibration
When observed variance estimates across time‐points are compared,
changes should reflect differences in common factor variation rather
than contamination by changes in residual variation. Equality between
pre‐ and post‐treatment residual variances is called strict invariance.
Changes in residual variance assume the presence of non‐uniform
recalibration response shift. Non‐uniform recalibration means that
some SQ‐48 item response options are associated with a greater level
of that item's specific construct and other response options are not.
For example, the response option “sometimes” is related to greater
levels of hopelessness (item 38) than the response option “rarely”
(Oort, 2005). These non‐uniform recalibrations result in changes in
variances that can not be attributed to change in common factor var-
iances, i.e. residuals (Oort, 2005). In order to test the equality of
residual variances, theta parameterization is used. Theta parameteriza-
tion is presently the most reliable method for constraining residual
variance with WLSMV estimation (Hirschfeld & von Brachel, 2014;
Muthén & Asparouhov, 2002). The theta approach fixes the residual
variance into 1 for all variables in the reference group (pre‐treatment).
In the strict invariance model, the residuals of the post‐treatment
group are also fixed into 1, in order to test the residual equality
between pre‐ and post‐treatment (Muthén & Asparouhov, 2002).
Equality constraints on corresponding factor loadings, thresholds,
and residual variances were computed in the strict invariance model
(Model D, see Table 4). If residual variances are equal between pre‐
and post‐treatment, Model D factor fit should be similar as Model C.
The differences in factor fit of Model D in comparison with Model C
were compared in order to detect discrepancies. Equality was
assumed, when the chi‐square difference test was insignificant
(p ≥ .05) and ΔCFI < 0.01 (Gregorich, 2006; Rutkowski, 2013). Analy-
ses were computed for the whole 7‐factor model at once and per sub-
scale separately. Items that were not invariant prior to the strict
invariance model were not constrained. If invariance on subscale level
in the strict model was not met, we further examined partial item‐level
measurement invariance (Wu, 2016).
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